Barrett, O., Shanbhag, A., Zaid, R., Miller, R. J., Lemley, M., Builoff, V., Liang, J., Kavanagh, P., Buckley, C., Dey, D., Berman, D. S., Slomka, P.
BackgroundPositron Emission Tomography (PET) myocardial perfusion imaging (MPI) is a powerful tool for predicting coronary artery disease (CAD). Coronary artery calcium (CAC) provides incremental risk stratification to PET-MPI and enhances diagnostic accuracy. We assessed additive value of CAC score, derived from PET/CT attenuation maps to stress TPD results using the novel 18F-flurpiridaz tracer in detecting significant CAD.
Methods and ResultsPatients from 18F-flurpiridaz phase III clinical trial who underwent PET/CT MPI with 18F-flurpiridaz tracer, had available CT attenuation correction (CTAC) scans for CAC scoring, and underwent invasive coronary angiography (ICA) within a 6-month period between 2011 and 2013, were included. Total perfusion deficit (TPD) was quantified automatically, and CAC scores from CTAC scans were assessed using artificial intelligence (AI)-derived segmentation and manual scoring. Obstructive CAD was defined as [≥]50% stenosis in Left Main (LM) artery, or 70% or more stenosis in any of the other major epicardial vessels. Prediction performance for CAD was assessed by comparing the area under receiver operating characteristic curve (AUC) for stress TPD alone and in combination with CAC score.
Among 498 patients (72% males, median age 63 years) 30.1% had CAD. Incorporating CAC score resulted in a greater AUC: manual scoring (AUC=0.87, 95% Confidence Interval [CI] 0.34-0.90; p=0.015) and AI-based scoring (AUC=0.88, 95%CI 0.85-0.90; p=0.002) compared to stress TPD alone (AUC 0.84, 95% CI 0.80-0.92).
ConclusionsCombining automatically derived TPD and CAC score enhances 18F-flurpiridaz PET MPI accuracy in detecting significant CAD, offering a method that can be routinely used with PET/CT scanners without additional scanning or technologist time.
CONDENSED ABSTRACTO_ST_ABSBackgroundC_ST_ABSWe assessed the added value of CAC score from hybrid PET/CT CTAC scans combined with stress TPD for detecting significant CAD using novel 18F-flurpiridaz tracer
Methods and resultsPatients from the 18F-flurpiridaz phase III clinical trial (n=498, 72% male, median age 63) who underwent PET/CT MPI and ICA within 6-months were included. TPD was quantified automatically, and CAC scores were assessed by AI and manual methods. Adding CAC score to TPD improved AUC for manual (0.87) and AI-based (0.88) scoring versus TPD alone (0.84).
ConclusionsCombining TPD and CAC score enhances 18F-flurpiridaz PET MPI accuracy for CAD detection
O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=110 SRC="FIGDIR/small/25330013v1_ufig1.gif" ALT="Figure 1">
View larger version (37K):
[email protected]@ba93d1org.highwire.dtl.DTLVardef@13eabd9org.highwire.dtl.DTLVardef@1845505_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical Abstract.C_FLOATNO Overview of the study design.
C_FIG